These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Zebrafish as a genetic model in pre-clinical drug testing and screening. Gibert Y; Trengove MC; Ward AC Curr Med Chem; 2013; 20(19):2458-66. PubMed ID: 23521675 [TBL] [Abstract][Full Text] [Related]
23. Designing Drug-Response Experiments and Quantifying their Results. Hafner M; Niepel M; Subramanian K; Sorger PK Curr Protoc Chem Biol; 2017 Jun; 9(2):96-116. PubMed ID: 28628201 [TBL] [Abstract][Full Text] [Related]
24. High-throughput metabolism-induced toxicity assays demonstrated on a 384-pillar plate. Yu KN; Kang SY; Hong S; Lee MY Arch Toxicol; 2018 Aug; 92(8):2501-2516. PubMed ID: 29974144 [TBL] [Abstract][Full Text] [Related]
25. Tox21 Enricher: Web-based Chemical/Biological Functional Annotation Analysis Tool Based on Tox21 Toxicity Screening Platform. Hur J; Danes L; Hsieh JH; McGregor B; Krout D; Auerbach S Mol Inform; 2018 May; 37(5):e1700129. PubMed ID: 29377626 [TBL] [Abstract][Full Text] [Related]
26. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment. Wetmore BA Toxicology; 2015 Jun; 332():94-101. PubMed ID: 24907440 [TBL] [Abstract][Full Text] [Related]
27. A versatile, automated and high-throughput drug screening platform for zebrafish embryos. Lubin A; Otterstrom J; Hoade Y; Bjedov I; Stead E; Whelan M; Gestri G; Paran Y; Payne E Biol Open; 2021 Sep; 10(9):. PubMed ID: 34472582 [TBL] [Abstract][Full Text] [Related]
28. Using high-content screening technology for studying drug-induced hepatotoxicity in preclinical studies. Donato MT; Gómez-Lechón MJ; Tolosa L Expert Opin Drug Discov; 2017 Feb; 12(2):201-211. PubMed ID: 27936962 [TBL] [Abstract][Full Text] [Related]
29. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files. Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533 [TBL] [Abstract][Full Text] [Related]
30. In Silico Study of In Vitro GPCR Assays by QSAR Modeling. Mansouri K; Judson RS Methods Mol Biol; 2016; 1425():361-81. PubMed ID: 27311474 [TBL] [Abstract][Full Text] [Related]
31. Integrated in vitro-in silico screening strategy for the discovery of antibacterial compounds. Nybond S; Ghemtio L; Nawrot DA; Karp M; Xhaard H; Tammela P Assay Drug Dev Technol; 2015; 13(1):25-33. PubMed ID: 25710544 [TBL] [Abstract][Full Text] [Related]
37. DiSCuS: an open platform for (not only) virtual screening results management. Wójcikowski M; Zielenkiewicz P; Siedlecki P J Chem Inf Model; 2014 Jan; 54(1):347-54. PubMed ID: 24364790 [TBL] [Abstract][Full Text] [Related]
38. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment. Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757 [TBL] [Abstract][Full Text] [Related]
39. High-Throughput Screening for Drug Combinations. Shinn P; Chen L; Ferrer M; Itkin Z; Klumpp-Thomas C; McKnight C; Michael S; Mierzwa T; Thomas C; Wilson K; Guha R Methods Mol Biol; 2019; 1939():11-35. PubMed ID: 30848454 [TBL] [Abstract][Full Text] [Related]
40. Leveraging high content screening for in vitro cytotoxicity assessment. Haskins JR Drug Discov Today; 2005; Suppl():1. PubMed ID: 23570159 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]